BBIO vs EXPD · rev $221.9M vs P/E 26, rev $10.60B
BridgeBio Pharma Inc (BBIO) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
BBIO currently screens at market cap $13.24B. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the BBIO and EXPD stock pages for the full models.
Not investment advice.